Dyslipidemia and fasting glucose impairment among HIV patients three years after the first antiretroviral regimen in a Brazilian AIDS outpatient clinic
Open Access
- 2 June 2013
- journal article
- Published by Elsevier in The Brazilian Journal of Infectious Diseases
- Vol. 17 (4) , 438-443
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- HIV and HAART-Associated DyslipidemiaThe Open Cardiovascular Medicine Journal, 2011
- Effects of First-Line Use of Nucleoside Analogues, Efavirenz, and Ritonavir-Boosted Protease Inhibitors on Lipid LevelsHIV Research & Clinical Practice, 2009
- Epidemiological Evidence for Cardiovascular Disease in HIV-Infected Patients and Relationship to Highly Active Antiretroviral TherapyCirculation, 2008
- State of the Science ConferenceCirculation, 2008
- HIV infection and high density lipoprotein metabolismAtherosclerosis, 2008
- Projections of Global Mortality and Burden of Disease from 2002 to 2030PLOS Medicine, 2006
- Cellular mechanisms of insulin resistance, lipodystrophy and atherosclerosis induced by HIV protease inhibitorsActa Physiologica Scandinavica, 2005
- Dramatic improvement in survival among adult Brazilian AIDS patientsAIDS, 2003
- Angiotensinogen 235T Allele “Dosage” Is Associated With Blood Pressure PhenotypesHypertension, 2003
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001